Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Anemia
100%
Recombinant Human
100%
Randomized Placebo-controlled Trial
100%
RhEPO
100%
Packed Cell Volume
42%
Placebo Groups
28%
Marrow
28%
Red Cell Mass
28%
No Response
14%
Number of Patients
14%
Placebo
14%
Adverse Events
14%
Multicenter Clinical Trial
14%
Acute Phase
14%
Mutagenic Effects
14%
Renal Failure
14%
Megakaryocytes
14%
Mass Measurement
14%
Cytogenetic Analysis
14%
Progenitor Cells
14%
Bone Marrow Cells
14%
Erythroid
14%
Creatinine Clearance
14%
Chronic Renal Insufficiency
14%
Maintenance Phase
14%
Medicine and Dentistry
Placebo
100%
Anemia
100%
Hematocrit
100%
Recombinant Erythropoietin
100%
Clinical Trial
20%
Low Drug Dose
20%
Adverse Event
20%
Granulocyte
20%
Renal Failure
20%
Chromosome Analysis
20%
Chronic Kidney Disease
20%
Progenitor Cell
20%
Mutagenic Activity
20%
Creatinine Clearance
20%
Hematopoietic Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Anemia
100%
Recombinant Erythropoietin
100%
Clinical Trial
25%
Creatinine
25%
Adverse Event
25%
Kidney Failure
25%
Chromium 51
25%
Chronic Kidney Failure
25%
Biochemistry, Genetics and Molecular Biology
Hematocrit
100%
Darbepoetin Alfa
100%
Clinical Trial
20%
Low Drug Dose
20%
Cytogenetics
20%
Megakaryocyte
20%
Progenitor Cell
20%
Creatinine Clearance
20%
Mutagenic Activity
20%
Hematopoietic Cell
20%
Polymorphonuclear Cell
20%
Immunology and Microbiology
Hematocrit
100%
Epoetin Beta
100%
Granulocyte
20%
Megakaryocyte
20%
Low Drug Dose
20%
Hematopoietic Cell
20%
Creatinine Clearance
20%
Mutagenic Activity
20%